AML, Department of Engineering Mechanics, Tsinghua University, Beijing 100084, China.
Center for Flexible Electronics Technology, Tsinghua University, Beijing 100084, China.
ACS Appl Mater Interfaces. 2021 May 12;13(18):21067-21075. doi: 10.1021/acsami.1c04653. Epub 2021 Apr 28.
Nowadays, controllable drug release is a vitally important strategy for cancer treatment and usually realized using implanting biocompatible devices. However, these devices need to be removed by another surgery after the function fails, which brings the risks of inflammation or potential death. In this article, a biodegradable flexible electronic device with controllable drug (paclitaxel) release was proposed for cancer treatment. The device is powered by an external alternating magnetic field to generate internal resistance heat and promote drug release loaded on the substrate. Moreover, the device temperature can even reach to 65 °C, which was sufficient for controllable drug release. This device also has similar mechanical properties to human tissues and can autonomously degrade due to the structure design of the circuit and degradable compositions. Finally, it is confirmed that the device has a good inhibitory effect on the proliferation of breast cancer cells (MCF-7) and could be completely degraded . Thus, its great biodegradability and conformity can relieve patients of second operation, and the device proposed in this paper provides a promising solution to complete conquest of cancer .
如今,可控药物释放是癌症治疗的一个至关重要的策略,通常通过植入生物相容性设备来实现。然而,这些设备在功能失效后需要通过另一次手术取出,这带来了炎症或潜在死亡的风险。在本文中,提出了一种具有可控药物(紫杉醇)释放功能的可生物降解柔性电子设备用于癌症治疗。该设备由外部交流磁场供电,以产生内部电阻热,从而促进基底上负载的药物释放。此外,该设备的温度甚至可以达到 65°C,足以实现可控药物释放。由于电路和可降解成分的结构设计,该设备还具有与人组织相似的机械性能,并能自动降解。最后,证实该设备对乳腺癌细胞(MCF-7)的增殖具有良好的抑制作用,并且可以完全降解。因此,其良好的生物降解性和顺应性可以减轻患者的二次手术负担,本文提出的设备为彻底征服癌症提供了一个有前途的解决方案。